Publications by authors named "P Miskiewicz"
Article Synopsis
- The study examined the impact of the COVID-19 pandemic on the diagnosis and treatment of appendicitis in children, comparing data from pre-pandemic and pandemic periods.
- During the pandemic, fewer children were admitted for suspected appendicitis, but the rate of surgeries increased significantly compared to the pre-pandemic period.
- Overall, patient outcomes remained stable, indicating that careful patient triage during the pandemic did not negatively affect the treatment of appendicitis in children.
The article presents the results of research on the impact of the use of an original, innovative method of deposition of Parylene C on the functional properties of fabrics with various potential applications (e.g., thermal and chemical protective clothing, packaging, covers and others).
View Article and Find Full Text PDFArticle Synopsis
- - Hyperbaric oxygen (HBO) therapy involves inhaling pure oxygen in a pressurized chamber and may influence circulating small extracellular vesicles (sEVs), which are important for health and disease.
- - A pilot study examined the effects of HBO therapy on sEV levels in 80 patients with necrotizing soft-tissue infections, sudden hearing loss, and aseptic bone necrosis, finding a significant increase in sEVs, particularly in the hearing loss group.
- - The elevated sEV levels suggest HBO therapy may reduce inflammation and oxidative stress, indicating a potential role of sEVs in understanding the therapy's effectiveness.
Purpose: We aimed to assess adrenal function following treatment of moderate-to-severe and active Graves' orbitopathy (GO) with intravenous methylprednisolone (IVMP) in weekly pulses in a cumulative dose of 4.5 or 7.5 g.
View Article and Find Full Text PDFPurpose: Dysthyroid optic neuropathy (DON) is a rare sight-threatening complication of Graves' disease. First-line treatment for DON consists of high-dose intravenous methylprednisolone (ivMP), followed by immediate orbital decompression (OD) if the response is poor or absent as recommended by the 2021 European Group on Graves' orbitopathy guidelines. The safety and efficacy of the proposed therapy have been proven.
View Article and Find Full Text PDF